|
NetSol Technologies, Inc. (Nasdaq CM: NTWK) is a worldwide provider of IT and enterprise software solutions to the global finance and leasing industry. We believe that our solutions constitute mission critical applications for clients, as they encapsulate end-to-end business processes, facilitating faster processing and increased transactions. NETSOL’s primary sources of revenues have been licensing, subscriptions, modification, enhancement and support of its suite of financial applications, under the brand name NFS Ascent® for leading businesses in the global finance and leasing space. With constant innovation being a major part of NETSOL’s DNA, we have enabled NFS Ascent® deployment on the cloud with several implementations already live and some underway. This shift to the cloud will enable NETSOL’s new customers to opt for a subscription-based pricing model rather than the traditional licensing model. NETSOL’s clients include blue chip organizations, Dow-Jones 30 Industrials, Fortune 500 manufacturers, financial institutions, global vehicle manufacturers and enterprise technology providers, all of which are serviced by NETSOL’s strategically placed support and delivery locations around the globe.
9-28-2021 |
Mr. Najeeb Ullah Ghauri
Chairman NetSol Technologies, Inc 23975 Park Sorrento Suite 250 Calabasas, CA 91302 United States 818-222-9195 http://www.netsoltech.com Nasdaq Stock Symbol NTWK |
Neurocrine Biosciences Inc
|
At Neurocrine Biosciences, our purpose is simple: to relieve suffering for people with great needs, but few options. For three decades, we have applied our unique insight into neuroscience to advance medicines for neurology, neuroendocrinology and neuropsychiatry-related disorders and diseases. Our efforts have resulted in United States Food and Drug Administration, or FDA, approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis* and uterine fibroids* and a diversified portfolio of investigational therapies with the potential to address unmet clinical needs of patients worldwide living with neurological, endocrine and psychiatric disorders.
2-11-2022 |
Dr. Kevin C. Gorman
Neurocrine Biosciences, Inc 12780 El Camino Real San Diego, CA 92130 United States 858-617-7600 http://www.neurocrine.com Nasdaq Stock Symbol NBIX |
Nevro Corp
|
We are a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. We have developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain, with the Senza® Omnia™ platform being our latest addition to the Senza family of products. Our proprietary, paresthesia-free 10 kHz Therapy, delivered by our Senza system, was demonstrated in our SENZA randomized controlled trial (RCT) to be superior to traditional SCS therapy, with 10 kHz Therapy being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy.
2-23-2022 |
Mr. D. Keith Grossman
Chairman Nevro Corp 1800 Bridge Parkway Redwood City, CA 94065 United States 650-251-0005 http://www.nevro.com NYSE Stock Symbol NVRO |
New Relic Inc
|
New Relic delivers a software platform for customers to land all of their telemetry data quickly and affordably in one place and derive actionable insights from that data in a unified front-end application. This category of software products is generally referred to as observability. Our customers use the New Relic platform to observe and operate the components of their digital infrastructure and provide a quality digital experience for their customers. With a unified front end, purpose built on top of the world’s most powerful telemetry data platform, the New Relic platform helps our users get a comprehensive and consistent view of their digital estate.
5-17-2022 |
Mr. William Staples
Chief Executive Officer New Relic, Inc 188 Spear Street Suite 1200 San Francisco, CA 94105 United States 650-777-7600 http://www.newrelic.com NYSE Stock Symbol NEWR |
NMI Holdings Inc
April 10, 2020
April 10, 2020
|
We provide mortgage insurance (referred to as mortgage insurance or MI) through our wholly-owned insurance subsidiaries, National Mortgage Insurance Corporation (NMIC) and National Mortgage Reinsurance Inc One (Re One). NMIC and Re One are domiciled in Wisconsin and principally regulated by the Wisconsin Office of the Commissioner of Insurance (Wisconsin OCI). NMIC is our primary insurance subsidiary, and is approved as an MI provider by the GSEs and is licensed to write MI coverage in all 50 states and D.C. Our subsidiary, NMI Services, Inc. (NMIS), provides outsourced loan review services to mortgage loan originators and our subsidiary, Re One, historically provided reinsurance coverage to NMIC in accordance with certain statutory risk retention requirements. Such requirements have been repealed and the reinsurance coverage provided by Re One to NMIC has been commuted. Re One remains a wholly-owned, licensed insurance subsidiary; however, it does not currently have active insurance exposures.
2-16-2022 |
Mr. Adam S. Pollitzer
Chief Executive Officer NMI Holdings, Inc 2100 Powell Street 12th Floor Emeryville, CA 94608 United States 855-530-6642 http://www.nationalmi.com Nasdaq Stock Symbol NMIH |
Nova LifeStyle Inc-It's Branded Product In The USA-Diamond Sofa
|
Nova LifeStyle, Inc. (“Nova LifeStyle” or the “Company”) is a U.S.-headquartered innovative designer and marketer of contemporary styled residential and commercial furniture formerly known as Stevens Resources, Inc. We were incorporated in the State of Nevada on September 9, 2009. The Company’s products are marketed through wholesale and retail channels as well as various online platforms worldwide.
4-08-0222 |
Ms. Thanh H. Lam
President Nova LifeStyle, Inc 6565 East Washington Boulevard Commerce, CA 90040 United States 323-888-9999 http://novalifestyle.com Nasdaq Stock Symbol NVFY |